Abhishek Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abhishek Kumar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ajit Dungdung
2 shared publicationsPiyush Kumar
2 shared publicationsAbhinav Kumar
1 shared publicationAbhishek Sinha
Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
1 shared publicationAditya Anurag
1 shared publicationAnitesh Kumar Gupta
1 shared publication
Latest Publications
- 5 August 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (6) , 103124
Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study
- 5 August 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (6) , 103124
Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study
- Open Access
- 18 June 2025
- Published by Wolters Kluwer Health in Neurology India
- Vol. 73 (4) , 836-837
Osmotic Demyelination Syndrome Without Dyselectrolytemia- An Awareness in Type 1 Diabetes Mellitus
- 18 June 2025
- Published by Wolters Kluwer Health in Neurology India
- Vol. 73 (4) , 836-837
Open AccessOsmotic Demyelination Syndrome Without Dyselectrolytemia- An Awareness in Type 1 Diabetes Mellitus
- 14 June 2021
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 10 (2) , 246-248
Wuchereria bancrofti infection causing pleural effusion
Presented here is a case of 46-year-old Hindu male with a complaint of progressive shortness of breath, chest discomfort, fever, generalized weakness, and malaise over 6 months. He had a past history of diabetes mellitus (on oral antihyperglycemic agents) and pulmonary tuberculosis, for which he took DOTS category-1 antitubercular treatment for 9 months about 10 years back. On examination, he was febrile with stable vitals; breath sounds diminished over the right side of chest with stony dull percussion note. A provisional diagnosis of right-sided pleural effusion was made, and chest X-ray posteroanterior (PA) view confirmed the same. Diagnostic thoracentesis was done, which showed that the fluid was exudative in nature. The microscopy of centrifuged fluid debris strikingly showed microfilariae of Wuchereria bancrofti. Eosinophils and macrophages were in plenty without any evidence of malignancy or lymphoma. The complete blood count confirmed eosinophil >30% with absolute eosinophil count to be 2400 cells. A diagnosis of filarial pleural effusion was made, and he was started on antihelminthic medication. There was a remarkable improvement in his symptoms over 14 days of starting the therapy. He was maintained on drugs for 6-8 months. There was complete resolution of his effusion and respiratory symptoms.
- 14 June 2021
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 10 (2) , 246-248
Wuchereria bancrofti infection causing pleural effusion
Presented here is a case of 46-year-old Hindu male with a complaint of progressive shortness of breath, chest discomfort, fever, generalized weakness, and malaise over 6 months. He had a past history of diabetes mellitus (on oral antihyperglycemic agents) and pulmonary tuberculosis, for which he took DOTS category-1 antitubercular treatment for 9 months about 10 years back. On examination, he was febrile with stable vitals; breath sounds diminished over the right side of chest with stony dull percussion note. A provisional diagnosis of right-sided pleural effusion was made, and chest X-ray posteroanterior (PA) view confirmed the same. Diagnostic thoracentesis was done, which showed that the fluid was exudative in nature. The microscopy of centrifuged fluid debris strikingly showed microfilariae of Wuchereria bancrofti. Eosinophils and macrophages were in plenty without any evidence of malignancy or lymphoma. The complete blood count confirmed eosinophil >30% with absolute eosinophil count to be 2400 cells. A diagnosis of filarial pleural effusion was made, and he was started on antihelminthic medication. There was a remarkable improvement in his symptoms over 14 days of starting the therapy. He was maintained on drugs for 6-8 months. There was complete resolution of his effusion and respiratory symptoms.
- 1 November 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (6) , 1951-1954
Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients
- 1 November 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (6) , 1951-1954
Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients
- 28 October 2020
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 8 (11) , 4130-4133
A young COVID-19 patient with mild symptoms and disseminated intravascular coagulation
Covid-19 pandemic in recent times has emerged as a major contributor to multisystemic thrombosis and related complications. Covid-19 leads to a syndrome of generalised systemic coagulopathy and acquired thrombophilia which manifests itself in the form of arterial, venous and microvascular thrombosis. The pathological mechanisms for covid-19 induced coagulopathy are yet to be clear however extensive research is underway and multiple insights have emerged recently. Here we report a case of young Covid-19 patient who presented with mild fever but severely deranged coagulation parameters and inflammatory markers. He was managed conservatively with Low molecular weight heparin, Fresh frozen plasma, Tab HCQS, Tab Doxycycline, Tab Ivermectin, Tab Zinc, Tab Vitamin C and responded well to treatment. He was later discharged after testing covid-19 negative. Screening of all confirmed cases for coagulopathy like D-dimer, FDP, platelet count, Prothrombin time may be done to identify high risk asymptomatic/mild cases which may cause further decrease in mortality.
- 28 October 2020
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 8 (11) , 4130-4133
A young COVID-19 patient with mild symptoms and disseminated intravascular coagulation
Covid-19 pandemic in recent times has emerged as a major contributor to multisystemic thrombosis and related complications. Covid-19 leads to a syndrome of generalised systemic coagulopathy and acquired thrombophilia which manifests itself in the form of arterial, venous and microvascular thrombosis. The pathological mechanisms for covid-19 induced coagulopathy are yet to be clear however extensive research is underway and multiple insights have emerged recently. Here we report a case of young Covid-19 patient who presented with mild fever but severely deranged coagulation parameters and inflammatory markers. He was managed conservatively with Low molecular weight heparin, Fresh frozen plasma, Tab HCQS, Tab Doxycycline, Tab Ivermectin, Tab Zinc, Tab Vitamin C and responded well to treatment. He was later discharged after testing covid-19 negative. Screening of all confirmed cases for coagulopathy like D-dimer, FDP, platelet count, Prothrombin time may be done to identify high risk asymptomatic/mild cases which may cause further decrease in mortality.